Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables

被引:50
作者
Bai, Yalai [2 ]
Tolles, Juliana
Cheng, Huan [2 ]
Siddiqui, Summar [2 ]
Gopinath, Arun [2 ]
Pectasides, Eirini [2 ]
Camp, Robert L. [2 ]
Rimm, David L. [2 ]
Molinaro, Annette M. [1 ]
机构
[1] Yale Univ, Div Biostat, LEPH 206, Sch Publ Hlth, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA
基金
美国国家卫生研究院;
关键词
antigenicity; biomarkers; core needle biopsy; ischemic time; phosphorylation; pre-analytical variables; resection tissue; GROWTH-FACTOR RECEPTOR; BREAST-CANCER; TISSUE; FIXATION; PHOSPHORYLATION; EXPRESSION; AKT; PHOSPHOPROTEIN; HETEROGENEITY; LOCALIZATION;
D O I
10.1038/labinvest.2011.75
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Pre-analytic variables, specifically cold ischemic time, have been implicated as key variables in the measurement of proteins by immunohistochemistry. To determine the significance and magnitude of antigenic loss due to pre-analytic variables, we have compared protein antigenicity in core needle biopsies, with essentially no cold ischemic time, with that in routinely processed tumor resection specimens. Two cohorts of matched core needle biopsies and tumor resections were collected with 20 matched pairs and 14 matched pairs, respectively. Both series were analyzed by quantitative immunofluorescence using the AQUA (R) method. Epitopes phospho-ERK, total ERK, phospho-AKT, total AKT, phospho-S6K1, total S6K1, estrogen receptor (ER), Ki67, cytokeratin and GAPDH were assessed. Detection levels for all phosphoepitopes were significantly decreased in tumor resections compared with biopsies while no significant change was seen in the corresponding total proteins. Of the other four proteins examined, ER and cytokeratin showed significant loss of antigenicity. This data suggest that measurement of phospho-protein antigenicity in formalin-fixed tissue by immunological methods is dramatically affected by pre-analytic variables. This study suggests that core needle biopsies are more accurate for assessment of tissue biomarkers. Laboratory Investigation (2011) 91, 1253-1261; doi:10.1038/labinvest.2011.75; published online 25 April 2011
引用
收藏
页码:1253 / 1261
页数:9
相关论文
共 33 条
[1]   EFFECTS OF HYPOXIA ON MORPHOLOGICAL AND BIOCHEMICAL CHARACTERISTICS OF RENAL EPITHELIAL-CELL AND TUBULE CULTURES [J].
ALLEN, J ;
WINTERFORD, C ;
AXELSEN, RA ;
GOBE, GC .
RENAL FAILURE, 1992, 14 (04) :453-460
[2]  
[Anonymous], 2009, R: A language and environment for statistical computing
[3]   Stability of phosphoprotein as a biological marker of tumor signaling [J].
Baker, AF ;
Dragovich, T ;
Ihle, NT ;
Williams, R ;
Fenoglio-Preiser, C ;
Powis, G .
CLINICAL CANCER RESEARCH, 2005, 11 (12) :4338-4340
[4]   Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].
Baselga, J ;
Tripathy, D ;
Mendelsohn, J ;
Baughman, S ;
Benz, CC ;
Dantis, L ;
Sklarin, NT ;
Seidman, AD ;
Hudis, CA ;
Moore, J ;
Rosen, PP ;
Twaddell, T ;
Henderson, IC ;
Norton, L .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744
[5]  
Bates D., 2009, Mixed-Effects Models in S and S-PLUS
[6]   Automated subcellular localization and quantification of protein expression in tissue microarrays [J].
Camp, RL ;
Chung, GG ;
Rimm, DL .
NATURE MEDICINE, 2002, 8 (11) :1323-1327
[7]   Clinical experience with gefitinib: An update [J].
Cappuzzo, F ;
Finocchiaro, G ;
Metro, G ;
Bartolini, S ;
Magrini, E ;
Cancellieri, A ;
Trisolini, R ;
Castaldini, L ;
Tallini, G ;
Crino, L .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 58 (01) :31-45
[8]   Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer [J].
Cappuzzo, F ;
Magrini, E ;
Ceresoli, GL ;
Bartolini, S ;
Rossi, E ;
Ludovini, V ;
Gregorc, V ;
Ligorio, C ;
Cancellieri, A ;
Damiani, S ;
Spreafico, A ;
Paties, CT ;
Lombardo, L ;
Calandri, C ;
Bellezza, G ;
Tonato, M ;
Crinò, L .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (15) :1133-1141
[9]   Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity [J].
Chen, Chuang ;
Peng, Jun ;
Xia, Heshun ;
Wu, Qiongshui ;
Zeng, Libo ;
Xu, Hao ;
Tang, Hongwu ;
Zhang, Zhiling ;
Zhu, Xiaobo ;
Pang, Daiwen ;
Li, Yan .
NANOTECHNOLOGY, 2010, 21 (09)
[10]   Quantitative analysis of estrogen receptor heterogeneity in breast cancer [J].
Chung, Gina G. ;
Zerkowski, Maciej P. ;
Ghosh, Sriparna ;
Camp, Robert L. ;
Rimm, David L. .
LABORATORY INVESTIGATION, 2007, 87 (07) :662-669